K.J. Harrison & Partners’s GSK GSK Stock Holding History

K.J. Harrison & Partners’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-4,000	Closed	-$216K	–	213
2016 Q3	$216K	Buy	+4,000	New	+$219K	0.1%	184
2015 Q3	–	Sell	-141,040	Closed	-$7.34M	–	156
2015 Q2	$7.34M	Sell	141,040 -8,000	-5%	-$450K	2.18%	8
2015 Q1	$8.6M	Sell	149,040 -12,128	-8%	-$695K	2.51%	5
2014 Q4	$8.61M	Buy	161,168 +113,168	+236%	+$6.33M	2.49%	4
2014 Q3	$2.76M	Hold	48,000	–	–	0.77%	44
2014 Q2	$3.21M	Hold	48,000	–	–	0.92%	39
2014 Q1	$3.19M	Hold	48,000	–	–	0.95%	39
2013 Q4	$3.41M	Hold	48,000	–	–	1%	36
2013 Q3	$3.01M	Hold	48,000	–	–	1.1%	34
2013 Q2	$3M	Buy	+48,000	New	+$3.05M	1.21%	32

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

K.J. Harrison & Partners's GSK Position: Q4 2016 in Review

K.J. Harrison & Partners sold out of GSK (GSK) in Q4 2016, closing a stake of 4,000 shares — an estimated $216K sold.

K.J. Harrison & Partners first reported a position in GSK in Q2 2013 and held it in 10 quarters. The position peaked at $8.61M in Q4 2014. 762 funds tracked by Wall St. Rank hold GSK as of Q4 2016.

K.J. Harrison & Partners reported no remaining GSK position as of Q4 2016 after selling out during the quarter.
K.J. Harrison & Partners sold 4,000 GSK shares in Q4 2016, an estimated $216K.
K.J. Harrison & Partners first reported a position in GSK in Q2 2013 and held it in 10 quarters.
K.J. Harrison & Partners's GSK position peaked at $8.61M in Q4 2014.
762 funds tracked by Wall St. Rank held GSK as of Q4 2016.

Based on K.J. Harrison & Partners's 13F filing for Q4 2016, filed 1 Feb 2017.